An intravitreal implant injection method for sustained drug delivery into mouse eyes

Using small molecule drugs to treat eye diseases carries benefits of specificity, scalability, and transportability, but their efficacy is significantly limited by a fast intraocular clearance rate. Ocular drug implants (ODIs) present a compelling means for the slow and sustained release of small mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Young Joo, Lin, Cheng-Hui, Wu, Man-Ru, Lee, Soo Hyeon, Yang, Jing, Kunchur, Caitlin R., Mujica, Elena M., Chiang, Bryce, Jung, Youn Soo, Wang, Sui, Mahajan, Vinit B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813043/
https://www.ncbi.nlm.nih.gov/pubmed/35128514
http://dx.doi.org/10.1016/j.crmeth.2021.100125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813043/
https://www.ncbi.nlm.nih.gov/pubmed/35128514
http://dx.doi.org/10.1016/j.crmeth.2021.100125

Ejemplares similares